Fabiani, Emiliano
 Distribuzione geografica
Continente #
NA - Nord America 2.409
EU - Europa 2.093
AS - Asia 1.378
SA - Sud America 259
AF - Africa 43
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.193
Nazione #
US - Stati Uniti d'America 2.366
DE - Germania 863
SG - Singapore 569
CN - Cina 511
SE - Svezia 396
BR - Brasile 220
UA - Ucraina 174
IT - Italia 136
FR - Francia 114
PL - Polonia 112
IE - Irlanda 69
GB - Regno Unito 62
VN - Vietnam 60
IN - India 54
ID - Indonesia 47
FI - Finlandia 45
RU - Federazione Russa 40
JP - Giappone 21
CA - Canada 20
BD - Bangladesh 19
NL - Olanda 16
TR - Turchia 16
ZA - Sudafrica 12
KR - Corea 11
MX - Messico 11
AR - Argentina 10
BE - Belgio 10
IQ - Iraq 10
AT - Austria 9
CI - Costa d'Avorio 9
CO - Colombia 9
HK - Hong Kong 9
AU - Australia 7
CZ - Repubblica Ceca 7
IR - Iran 7
LT - Lituania 7
CL - Cile 6
GR - Grecia 6
JO - Giordania 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
BG - Bulgaria 5
ES - Italia 5
PK - Pakistan 5
DZ - Algeria 4
EC - Ecuador 4
EG - Egitto 4
IL - Israele 4
KE - Kenya 4
TH - Thailandia 4
VE - Venezuela 4
BB - Barbados 3
CH - Svizzera 3
HR - Croazia 3
JM - Giamaica 3
MA - Marocco 3
NO - Norvegia 3
PY - Paraguay 3
UZ - Uzbekistan 3
HN - Honduras 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
PE - Perù 2
SA - Arabia Saudita 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AO - Angola 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
MK - Macedonia 1
MR - Mauritania 1
NI - Nicaragua 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 6.193
Città #
Chandler 352
Singapore 285
Ashburn 166
Jacksonville 120
Warsaw 109
Dearborn 92
Los Angeles 86
Nanjing 86
Houston 85
Beijing 82
San Mateo 79
Chicago 73
Ann Arbor 72
New York 68
Dublin 64
Wilmington 56
Woodbridge 56
Buffalo 47
Fairfield 45
Jakarta 41
Nürnberg 41
Bremen 38
Dallas 37
Milan 36
Munich 33
Nanchang 32
Hefei 31
Seattle 31
Lawrence 28
Redwood City 27
Salt Lake City 27
Moscow 26
Boston 25
São Paulo 25
Cattolica 21
Shanghai 21
Marseille 20
Frankfurt am Main 18
Ho Chi Minh City 18
Kunming 17
Chatsworth 16
Hanoi 16
Hangzhou 15
Guangzhou 14
Leawood 14
Auburn Hills 13
Changsha 13
Tampa 13
Zhengzhou 13
London 12
Shenyang 12
Cambridge 11
Elk Grove Village 11
Princeton 11
Pune 11
Tianjin 11
Izmir 10
Mountain View 10
Rome 10
Tokyo 10
Abidjan 9
Brussels 9
Hong Kong 9
Jiaxing 9
University Park 9
Atlanta 8
Augusta 8
Fremont 8
Hebei 8
Helsinki 8
Jinan 8
Kent 8
Rio de Janeiro 8
Washington 8
Brooklyn 7
Lanzhou 7
Miami 7
Amman 6
Belo Horizonte 6
Boardman 6
Denver 6
Edinburgh 6
Enterprise 6
Lancaster 6
Montreal 6
Nuremberg 6
Orem 6
San Jose 6
Santa Clara 6
Seoul 6
Toronto 6
Amsterdam 5
Baghdad 5
Baku 5
Barletta 5
Cape Town 5
Costa Mesa 5
Haiphong 5
Las Vegas 5
Monmouth Junction 5
Totale 3.129
Nome #
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature 402
Fanconi anemia gene variants in therapy-related myeloid neoplasms 300
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 241
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 214
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 208
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 207
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 190
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 173
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 170
Why methylation is not a marker predictive of response to hypomethylating agents 170
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 168
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 167
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 167
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 162
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 161
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 160
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. 158
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 156
Epigenetic changes in therapy-related MDS/AML 153
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 152
Similarities and differences between therapy-related and elderly acute myeloid leukemia 149
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 144
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 143
Endothelial progenitor cell dysfunction in myelodysplastic syndromes: possible contribution of a defective vascular niche to myelodysplasia 140
Children with special health care needs attending emergency department in Italy: analysis of 3479 cases 138
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine 131
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes 129
PU.1 and CEBPA expression in acute myeloid leukemia. 128
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 121
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. 120
Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. 116
Development of a High-Resolution Melting Curve Analysis Screening Test for SRSF2 Splicing Factor Gene Mutations in Myelodysplastic Syndromes 114
Clonal evolution in therapy-related neoplasms 114
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 111
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome 110
Therapy-related myeloid neoplasms: Clinical perspectives 97
Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapy 95
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells 73
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 66
In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome 58
Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis 50
Totale 6.226
Categoria #
all - tutte 21.422
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.422


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021389 0 0 0 0 0 59 94 7 48 45 115 21
2021/2022396 45 40 5 11 31 19 5 76 17 40 51 56
2022/2023960 143 145 78 181 56 100 36 93 76 3 36 13
2023/2024380 21 96 10 15 18 95 5 15 5 7 45 48
2024/2025973 19 22 71 22 80 15 47 36 112 59 384 106
2025/20261.042 299 50 111 199 363 20 0 0 0 0 0 0
Totale 6.226